Major Histocompatibility Antigens: An Introduction

  • Roman M. Chicz
  • Robert G. Urban


Specific immunity depends on the gene products encoded within the major histocompatibility complex (MHC). As the name suggests, the MHC was first identified as a group of genetic loci which influenced the type of immunological responses which followed tissue transplantation. Over 20 years ago, the involvement of MHC molecules in the interaction between B and T cells was demonstrated to be specific and restricted.1–3 As it turns out, the products of two families of MHC encoded genes, termed class I and class II, are the primary molecules used by the immune system to educate immune cells (not to recognize self) and subsequently to activate the entire system following recognition of foreign matter. MHC class I and class II molecules are highly polymorphic membrane expressed proteins which function by binding peptides and “presenting” them to T cells. The last two decades have witnessed a wealth of discovery on MHC molecules and antigen presentation in general, yet more and more detail continues to be uncovered. This chapter is intended to review some of the hallmark observations made in the last five years and to prepare those newly interested in immunology for the more detailed chapters that follow.


Major Histocompatibility Complex Human Leukocyte Antigen Major Histocompatibility Complex Class Peptide Binding Human Leukocyte Antigen Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kindred B, Shreffler DC. H-2 dependence of co-operation between T and B cells in vivo. J Immunol 1972; 109: 940–43.Google Scholar
  2. 2.
    Shevach EM, Rosenthal AS. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement of histocompatible macrophages and lymphocytes. J Exp Med 1973; 1973: 1194–212.Google Scholar
  3. 3.
    Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974; 248: 701–02.CrossRefGoogle Scholar
  4. 4.
    de la Salle H, Hanau D, Fricker D et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994; 265: 237–41.CrossRefGoogle Scholar
  5. 5.
    Bjorkman PJ, Saper MA, Samraoui B et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506–12.CrossRefGoogle Scholar
  6. 6.
    Bjorkman PJ, Saper MA, Samraoui B et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–18.CrossRefGoogle Scholar
  7. 7.
    Garrett TPJ, Saper MA, Bjorkman PJ et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989; 342: 692–96.CrossRefGoogle Scholar
  8. 8.
    Boon T, Cerottini J-C, Van den Eynde B et al. Tumor antigens recognized by T lymphocytes. In: Paul W, ed. Annual Review of Immunology. vol 12.: Annual Reviews, Inc, 1994: 337–65.Google Scholar
  9. 9.
    Cox AL, Skipper J, Chen Y et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264: 716–19.CrossRefGoogle Scholar
  10. 10.
    Mandelboim O, Berke G, Fridkin M et al. CTL induction by a tumor associated antigen octapeptide derived from a murine lung carcinoma. Nature 1994; 369: 67–71.CrossRefGoogle Scholar
  11. 11.
    Castelli C, Storkus WJ, Maeurer MJ et al. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8’ cytotoxic T lymphocytes. J Exp Med 1995; 181: 363–68.CrossRefGoogle Scholar
  12. 12.
    den Haan JMM, Sherman NE, Blokland E et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995; 268: 1476–80.CrossRefGoogle Scholar
  13. 13.
    Chicz RM, Urban RG, Gorga JC et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27–47.CrossRefGoogle Scholar
  14. 14.
    Rovero P, Riganelli D, Furci D et al. The importance of secondary anchor residue motifs of HLA class I proteins: A chemometric approach. Mol Immunol 1994; 31: 549–54.CrossRefGoogle Scholar
  15. 15.
    Rognan D, Scapozza L, Folkers G et al. Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes. Biochem 1994; 33: 11476–85.CrossRefGoogle Scholar
  16. 16.
    D’Amaro J, Houbiers JGA, Drijfhout JW et al. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum Immunol 1995; 43: 13–18.CrossRefGoogle Scholar
  17. 17.
    Meister GE, Roberts CGP, Berzofsky JA et al. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 1995; 13: 581–91.CrossRefGoogle Scholar

Copyright information

© R.G. Landes Company 1996

Authors and Affiliations

  • Roman M. Chicz
  • Robert G. Urban

There are no affiliations available

Personalised recommendations